Effects of Different Collagen Formulations on Knee Osteoarthritis
A legfontosabb adatok
- Ki végzi
- Cihangir Türemiş
- Hol
- Izmir (Törökország)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 45 fő, tervezett
- Kezdés
- 2026. okt. 1.
- Várható befejezés
- 2027. máj. 1.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
- A vizsgált kezelések
- 10g Hydrolyzed Collagen
- 5g Bioactive Collagen Peptide
- Placebo (Maltodextrin)
- A regiszteradat frissítve
- 2026. szeptember 2.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with knee osteoarthritis (wear of the knee joint) and long-lasting knee pain. It compares two collagen supplements with a placebo (dummy powder) taken daily for 8 weeks.
- Életkor
- 35 to 65 years
- Nem
- All sexes
- A betegség stádiuma
- Primary knee osteoarthritis confirmed by exam and X-ray, Kellgren-Lawrence grade 2 or 3 in the affected knee. Knee pain for at least the last 3 months. The summary says one knee is affected.
- Korábbi kezelés
- No joint injections (corticosteroid, hyaluronic acid, PRP, stem cell, etc.) into the affected knee in the last 6 months. No regular use of joint supplements (glucosamine, chondroitin, MSM, other collagen) in the last 3 months. No new supplements or physical therapy during the 8 weeks.
A részvétel fő kizáró okai
- Kellgren-Lawrence grade 4, or grade 0-1 osteoarthritis
- Major leg surgery, major injury or ligament reconstruction on the affected knee
- Inflammatory joint disease such as rheumatoid arthritis, ankylosing spondylitis or gout
- Allergy or intolerance to beef products or maltodextrin
- Being pregnant or breastfeeding
A regiszter feltételei, szó szerint
Mind a 14 feltétel megnézéseKevesebb
Ki vehet részt
- Adults aged between 35 and 65 years
- Clinical and radiographic diagnosis of primary knee osteoarthritis according to the American College of Rheumatology (ACR) criteria
- Radiographic severity of Kellgren-Lawrence grade 2 or 3 in the affected knee
- Experiencing chronic knee pain for at least the last 3 months
- Willingness to refrain from starting any new dietary supplements or physical therapy programs during the 8-week study period
- Ability to read, understand, and provide written informed consent, as well as independently complete the patient-reported outcome questionnaires
Ki nem vehet részt
- History of major lower extremity surgery, major trauma, or previous ligament reconstruction (e.g., ACL reconstruction) on the affected knee
- History of intra-articular injections (corticosteroid, hyaluronic acid, PRP, stem cell, etc.) to the affected knee within the last 6 months
- Presence of systemic inflammatory joint diseases (e.g., rheumatoid arthritis, ankylosing spondylitis, gout)
- Known allergy, hypersensitivity, or intolerance to bovine (beef) products or maltodextrin
- Severe neurological, psychiatric, or cognitive disorders that would prevent accurate completion of the pain and central sensitization questionnaires
- Severe knee osteoarthritis (Kellgren-Lawrence grade 4) or mild/doubtful osteoarthritis (Kellgren-Lawrence grade 0-1)
- Routine use of other joint health supplements (e.g., glucosamine, chondroitin, MSM, other collagen products) within the last 3 months
- Current pregnancy or lactation
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 35 és 65 év között vagy?
Helyszínek itt: Törökország
- Cesme Alper Cizgenakat State HospitalIzmir, TörökországContact: Cihangir Türemiş, Dr.Toborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this study is to evaluate and compare the effects of two different collagen supplement formulations on pain, physical function, and overall quality of life in adults with knee osteoarthritis.
A teljes eredeti leírásKevesebb
Knee osteoarthritis is a common joint disease characterized by cartilage degeneration, which leads to chronic pain and reduced mobility. While collagen supplements are frequently used to support joint health, their clinical effectiveness is usually measured using traditional pain scales. However, osteoarthritis pain is complex and multidimensional, often involving different patterns (such as constant or intermittent pain) and central neurological sensitization. This study aims to use a holistic approach to understand how collagen supplements affect these complex pain experiences using comprehensive patient-reported outcome measures.
Participants in this study will be adults between the ages of 35 and 65 who have been diagnosed with unilateral knee osteoarthritis (Kellgren-Lawrence grade 2 or 3).
Participants will be randomly assigned to one of three groups:
Hydrolyzed Collagen Group: Participants will consume a daily sachet containing 10 grams of enzymatically hydrolyzed bovine collagen peptide.
Bioactive Collagen Peptide Group: Participants will consume a daily sachet containing 5 grams of lower molecular weight bovine collagen peptide mixed with 5 grams of maltodextrin.
Placebo Group: Participants will consume a daily sachet containing 10 grams of maltodextrin (with no active collagen or protein), matching the active supplements in taste, smell, and appearance.
All participants will take their assigned supplement once daily for 8 weeks. To ensure unbiased results, the study is double-blind, meaning neither the participants nor the research staff evaluating the outcomes will know which group a participant is in.
Researchers will assess the participants at the beginning of the study (baseline) and at the end of the 8-week intervention. Assessments will be conducted using various established questionnaires to measure joint stiffness, physical limitations, general quality of life, and specific pain patterns, including central sensitization.
The study will be conducted at the Orthopedics and Traumatology Clinic of Cesme Alper Cizgenakat State Hospital in Türkiye. By looking beyond traditional clinical scales, this research aims to provide a deeper understanding of how different collagen formulations can improve the daily lives and complex pain symptoms of patients living with knee osteoarthritis.
A vizsgálat 3 csoportja
- Hydrolyzed CollagenA vizsgált kezelés
Participants in this arm will receive a daily single-use sachet containing 10 grams of enzymatically hydrolyzed bovine collagen peptide. The supplement is to be dissolved in water and consumed once daily for 8 weeks.
Kezelés: 10g Hydrolyzed Collagen
- Bioactive Collagen PeptideA vizsgált kezelés
Participants in this arm will receive a daily single-use sachet containing 5 grams of lower molecular weight bovine collagen peptide mixed with 5 grams of maltodextrin. The supplement is to be dissolved in water and consumed once daily for 8 weeks.
Kezelés: 5g Bioactive Collagen Peptide
- PlaceboPlacebo, összehasonlításként
Participants in this arm will receive a daily single-use sachet containing 10 grams of maltodextrin, with no active collagen or protein. The placebo is completely identical to the active supplements in appearance, color, smell, and taste. It is to be dissolved in water and consumed once daily for 8 weeks.
Kezelés: Placebo (Maltodextrin)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Comparison of the Effects of Different Collagen Formulations on Pain, Function, and Quality of Life in Patients With Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07800780: ki vehet részt
- A regiszteradat frissítve
- 2026. szeptember 2.